Immune modulation is a new emerging field in the medical treatment of viral infections. Immune modulation works by introducing an agent into the body that boosts specific areas of the immune system, most notably the T Lymphocytes cells. It is our belief, along with many other members of the medical community, that stimulating areas of the immune system will lead to an increase in the probability of your body naturally fighting off viral infections.

Since an immune modulator boost effectiveness of the viral immune system it is our belief that immune modulation could be an effective treatment in a wide variety of viral infections.

Imunovir™ has been approved since 1971 for the treatment of cell mediated immune deficiencies associated with various viral infections. It has been on the market for over 30 years and is currently registered in 43 countries world wide for a variety of indications. These include the treatment of HPV, HSV, VZV, CMV, EBV, measles virus infections, SSPE, and chronic fatigue syndrome.

Inosine pranobex is available in 500mg tablets (Isoprinosine® / Imunovir® / Delimmun®) as well as syrup containing 250mg of inosine pranobex per
5ml (Imunovir™)

Imunovir™ is a registered trademark of Newport Pharmaceuticals.